Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis / 中西医结合学报
Journal of Integrative Medicine
;
(12): 147-155, 2014.
Article
in English
| WPRIM
| ID: wpr-308201
ABSTRACT
Liver fibrosis is a primary cause of liver cirrhosis, and even hepatocarcinoma. Recently, the usage of mesenchymal stem cells (MSCs) has been investigated to improve liver fibrosis. It has been reported that the differentiation, proliferation and migration of MSCs can be regulated by traditional Chinese medicine treatment; however, the mechanisms are still unclear. In this article, the authors review the characteristics of MSCs such as multidirectional differentiation and homing, and its application in animal experiments and clinical trials. The authors also list areas that need further investigation, andlook at the future prospects of clinical application of MSCs.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Physiology
/
Therapeutics
/
Cell Differentiation
/
Cell Movement
/
Clinical Trials as Topic
/
Combined Modality Therapy
/
Cell Biology
/
Mesenchymal Stem Cell Transplantation
/
Mesenchymal Stem Cells
/
Liver Cirrhosis
Type of study:
Diagnostic study
Limits:
Animals
/
Humans
Language:
English
Journal:
Journal of Integrative Medicine
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS